Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) can specifically promote the division and proliferation of endothelial cells and the revascularization, finally induce angiopoiesis. Recently, VEGF-based gene therapy has been gradually used in clinical trials, but some limits on usually used vectors deserve further studies, including the low transfection efficiency of plasmid vector, the immunogenicity of adnovirus vector to host cells and the potential risk of infection. OBJECTIVE: To construct the non-pathogenic recombinant adeno-associated vires (AAV) co-expressing human vascular endethelial growth factor 165 (hVEGF165) and green fluorescent protein (GFP) label and measure the virus titer and assess its biological activity.DESIGN, TIME AND SETTING: The open experiment was performed at the Vitrus Laboratory of Shanxi Provincial Center for Disease Control and Prevention from March to September 2007.MATERIALS: AAV-293 virus packaging cell line, AAV HT-1080 cells were purchased from Swatagene, USA. E.coli DH5α was a stocked strain from Shanxi Provincial Center for Disease Control and Prevention. AAV Helper Free System (pAAV-IRES-GFP vector containing GFP label) was purchased from Stratagene, USA. Plasmid pUC18-hVEGF165 was constructed previously by Dr.Shi from Department of Orthopaedics of Second Affiliated Hospital of Xi'an Jiaotong University.METHODS: The hVEGF165 gone from plasmid pUC18-hVEGF165 was amplified and inserted into plasmid pAAV-IRES-hrGFP. Then recombinant plasmid pAAV-hVEGF165-IRES-hrGFP, pAAV-RC and pAAV-Helper were co-transfected into AAV-293 cells to complete rAAV-hVEGF165-IRES-hrGFP packaging through homologous recombination. The efficiency of A.AV packaging was monitored under a fluorescent microscope, and the recombinant viral particles were harvested from infected AAV-293 cells and further concentrated and purified. The recombinant virus infected the AAV-HT1080 cells, the virus titer was measured by fluorescence counting, and the recombinant AAV-hVEGF165-IRES-hrGFP was verified by the amplification of the exogenous gene of hVEGF165 from virus genome.MAIN OUTCOME MEASURES: Virus packaging efficiency was monitored under the fluorescence microscope. Virus filer was measured by fluorescent counting. The packaging of recombinant virus was determined by the amplification of the exogenous hVEGF165 gene.RESULTS: The amplified products were verified as hVEGF165 gene by DNA sequencing, and the recombinant pAAV-hVEGF165-IRES-hrGFP was confirmed by double digestion. The system provided a high packaging ratio of over 95% and the purified recombinant virus had a high titer of 5.5×1011 vp/mL. The recombinant virus was confirmed by exogenous human VEGF165 gene from virus genome.CONCLUSION: The non-pathogenic rAAV-hVEGF165-GFP simultaneously carrying hVEGF165 and GFP 1abel is successfully constructed, with a high titer and satisfying biological activity.

Construction and Characterization of Recombinant CVI988 Expressing the Green Fluorescent Protein

Construction and Expression of the Eukaryotic Expression Vector Pci-Chil-2-egfp and Enhancement of AIV Vaccine

Construction of Transferring Vector of Marek's Disease Virus Expressing GFP Gene and Its Primary Application

Generation of Recombinant Vaccinia Viruses Via Green Fluorescent Protein Selection

Construction and Transfection Experiment of a Goose Circovirus Infectious Clone

Expression of the Recombinant Capsid Protein of Goose Circovirus in E.coli System

Construction and Characterization of a Recombinant Reticuloendotheliosis Virus Expressing Enhanced Green Fluorescent Protein

Construction of Cell Line Stably Expressing IBDV VP2 Protein Mutants

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

Infectious bursal disease virus as a replication-incompetent viral vector expressing green fluorescent protein

Development and characterization of a recombinant Senecavirus A expressing enhanced green fluorescent protein

Construction of Green Fluorescent Protein Retroviral Vector and Its Expression in Various Cell Types

[Construction and Expression of Retroviral Vector Encoding Enhanced Green Fluorescent Protein]

Construction of a novel enhanced green fluorescent (EGFP) tagged insect-baculovirus transference vector and preparation of EGFP

Construction of the recombinant Listeria monocytogenes mutant expressing green fluorescent protein

Development and Characterization of a cDNA-Launch Recombinant Simian Hemorrhagic Fever Virus Expressing Enhanced Green Fluorescent Protein: ORF 2b’ Is Not Required for In Vitro Virus Replication

Construction and Identification of Recombinant Baculovirus Vector to Coexpress GDNF and EGFP Gene

Construction and Identification of Recombinant Adeno- Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor and Green Fluorescent Protein

Construction of the Expression Vector with Double Report Gene of EGFP-LacZ and Its Expression in Vitro

Construction and Characterization of a Streptococcus Suis Serotype 2 Recombinant Expressing Enhanced Green Fluorescent Protein.

Construction and expression of enhanced green fluorescent protein and HGF co-expression vector